Advertisement
Canada markets closed
  • S&P/TSX

    23,956.82
    -77.01 (-0.32%)
     
  • S&P 500

    5,738.17
    -7.20 (-0.13%)
     
  • DOW

    42,313.00
    +137.89 (+0.33%)
     
  • CAD/USD

    0.7401
    -0.0025 (-0.33%)
     
  • CRUDE OIL

    68.64
    +0.97 (+1.43%)
     
  • Bitcoin CAD

    88,726.02
    -597.48 (-0.67%)
     
  • XRP CAD

    0.84
    +0.05 (+5.76%)
     
  • GOLD FUTURES

    2,680.80
    -14.10 (-0.52%)
     
  • RUSSELL 2000

    2,224.70
    +14.83 (+0.67%)
     
  • 10-Yr Bond

    3.7490
    -0.0420 (-1.11%)
     
  • NASDAQ

    18,119.59
    -70.70 (-0.39%)
     
  • VOLATILITY

    16.96
    +1.59 (+10.34%)
     
  • FTSE

    8,320.76
    +35.85 (+0.43%)
     
  • NIKKEI 225

    39,829.56
    +903.93 (+2.32%)
     
  • CAD/EUR

    0.6625
    -0.0016 (-0.24%)
     

IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug

IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug

TG Therapeutics stock rose Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi.